Angelini Ventures co-leads Series A financing in Neumirna Therapeutics - PharmaTimes Investment to support RNA therapeutics for epilepsy and neurological disorders

#Biotech #BioPharma #AngeliniVentures #NeumirnaTherapeutics #RNAtherapeutics #epilepsy #neurology #LifeSciences #AntisenseOligonucleotidetherapy #ASOtherapy #drugresistantepilepsy #Parkinsonsdisease #drugdiscovery #microRNAs #miRNAs #microRNAtargeteddrugs
pharmatimes.com/news/angelin...